lobbying_activities: 3964253

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	is_no_activity	is_termination	received_date
3964253	f0f962c4-0f83-49e0-acde-4682965351cb	Q2	MCDERMOTT+ LLC	401103287	PATIENTS FOR AFFORDABLE DRUGS NOW	2026	second_quarter	MMM	Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.	HOUSE OF REPRESENTATIVES,SENATE	0	0	2026-07-06T10:49:38-04:00